Cerevel Therapeutics Holdings logo
Cerevel Therapeutics Holdings CERE
$ 44.96 0.0%

Quarterly report 2024-Q1
added 05-08-2024

report update icon

Cerevel Therapeutics Holdings Cash Flow 2011-2024 | CERE

Annual Cash Flow Cerevel Therapeutics Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-342 M -293 M -179 M -118 M -70.7 M - - - - - - - -

Depreciation & Amortization

5.63 M 4.9 M 2.73 M 397 K 177 K - - - - - - - -

Accounts Payables

11.9 M 10.1 M 11.3 M 4.99 M - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Cerevel Therapeutics Holdings

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

-120 M - - - -94.9 M - -206 M - -67.6 M - -126 M - -36.4 M - -76.1 M -446 K -29.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

1.54 M - - - 1.32 M - 3.61 M - 1.12 M - 1.64 M - 63 K - 336 K 285 K 95 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

10.8 M 11.9 M 11.5 M 9.39 M 7.32 M 10.1 M 15 M - 8.18 M 11.3 M 5.44 M 4.99 M 7.76 M 4.99 M 4.99 M 4.99 M 4.99 M 2.11 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency